Amitabh Chandra

What is a fair price for a lifesaving cure?

Share This Talk

TEDMED Talks are available, free to the world, thanks to our partners.

About Amitabh Chandra

Health care economist Amitabh Chandra examines the unique effects that economics and market factors have on the development of precision medicine. Amitabh’s research focuses on productivity, pricing and innovation in healthcare, medical malpractice, and racial disparities in healthcare. His research has been published by numerous research journals, and has received extensive media coverage. An advocate for health equity, Amitabh has testified to the United States Senate and the United States Commission on Civil Rights. He is a Professor at Harvard Business School and the Harvard Kennedy School of Government, and serves as Chair Editor of the Review of Economics and Statistics. Amitabh is also an elected member of the National Academy of Medicine.

Find out more

About This Talk

Value-based drug pricing helps us to understand the maximum amount of money we're willing to pay for treatments that could benefit patients and save lives. The idea is simple: We should pay more for drugs that do more and generate more life, and we should pay less for drugs that do less. However, what happens when the value-based price for a tremendous drug is legitimately in the millions of dollars?

Healthcare economist Amitabh Chandra acknowledges that although value-based pricing is an appealing idea, it isn't the right model if we want to be sure that the amazing drugs of the future—from revolutionary cures to regenerative medicines—are accessible and affordable for all. Tune in to Amitabh's 2017 TEDMED Talk to learn more about the innovative models he believes could help to ensure that everyone is able to benefit from the lifesaving drugs of tomorrow. 

Other Talks from TEDMED 2017